Establishment Labs/$ESTA

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Establishment Labs

Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.

Ticker

$ESTA
Primary listing

Industry

Health Care Equipment & Supplies

Headquarters

Alajuela, Costa Rica

Employees

1,034

ISIN

VGG312491084

ESTA Metrics

BasicAdvanced
$1.1B
-
-$3.12
0.73
-

What the Analysts think about ESTA

Analyst ratings (Buy, Hold, Sell) for Establishment Labs stock.

Bulls say / Bears say

Establishment Labs reported a 41% increase in total revenue for Q4 2024 compared to the same period in 2023, indicating strong growth momentum. (insidermonkey.com)
The company has successfully reduced operating expenses by $12.5 million in 2024 while expanding its commercial operations in the United States, demonstrating effective cost management. (insidermonkey.com)
Analysts have set a consensus price target of $57.40 for Establishment Labs, suggesting potential upside from its current trading price. (marketbeat.com)
Establishment Labs reported a net loss of $0.98 per share in Q4 2024, missing analysts' consensus estimates of a $0.64 loss, indicating financial underperformance. (marketbeat.com)
The company's debt-to-equity ratio stands at 5.94, suggesting a high level of leverage that could pose financial risks. (marketbeat.com)
Despite revenue growth, Establishment Labs has not yet achieved profitability, which may concern investors seeking immediate returns. (insidermonkey.com)
Data summarised monthly by Lightyear AI. Last updated on 6 Jun 2025.

ESTA Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

ESTA Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $ESTA

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events
FAQs